Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence

The Journal of Urology
Shahar MadjarCharles L Secrest

Abstract

Durasphere is gaining popularity as a bulking agent for treating women with stress urinary incontinence. We present a series of patients with periurethral mass formation following Durasphere injection. The charts of 135 women with a mean age of 69.4 years (range 46 to 83) who underwent Durasphere periurethral injections were retrospectively reviewed. Patients who had a periurethral mass were identified and their clinical data were collected and analyzed. Four patients (2.9%) were diagnosed with periurethral mass formation 12 to 18 months (average 14.7) following a Durasphere injection. Clinical presentation varied, including irritative voiding symptoms, pelvic pain and urinary incontinence. All patients were found to have a tender and tense periurethral mass. A radiopaque mass was revealed during videourodynamic study in 1 patient. Incision, and transvaginal and endoscopic drainage or transvaginal excision were used to treat these masses. Intraoperative and pathological findings as well as operative outcomes are presented. Irritative or obstructing voiding symptoms, pelvic pain or a periurethral mass in patients with a history of Durasphere or other periurethral bulking agent injection should alert the physician to the possibil...Continue Reading

References

Jan 1, 1993·Neurourology and Urodynamics·P J KiilholmaP J Klemi
Apr 16, 1998·American Journal of Obstetrics and Gynecology·R L HarrisR C Bump
Jun 4, 1998·Urology·M A Wainstein, C G Klutke
Oct 9, 1998·Obstetrics and Gynecology·M T McLennan, A E Bent
Jul 18, 2001·The Journal of Urology·J Q Clemens, W Bushman
Nov 25, 2003·The Journal of Urology·Shahar MadjarCharles L Secrest

❮ Previous
Next ❯

Citations

Sep 4, 2007·International Urogynecology Journal and Pelvic Floor Dysfunction·Edmund Y KoSteven P Petrou
Jun 19, 2012·International Urogynecology Journal·Stefan MohrAnnette Kuhn
Aug 28, 2009·Current Urology Reports·Ahmed F KotbJacques Corcos
Jul 22, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J J TjandraH C H Yeh
Apr 1, 2007·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Bertil F M Blok, Jacques Corcos
Aug 11, 2012·The Urologic Clinics of North America·Dani Zoorob, Mickey Karram
Aug 11, 2012·The Urologic Clinics of North America·W Stuart Reynolds, Roger R Dmochowski
Dec 2, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·C LoiselP Grise
Jul 27, 2015·International Urogynecology Journal·Anushuya Devi KasiStergios K Doumouchtsis
May 31, 2015·Current Urology Reports·Alice Yu, Lysanne Campeau
Jul 12, 2016·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Gaurav KhatriIvan Pedrosa
Nov 21, 2012·Journal of Korean Medical Science·So Young ChunTae Gyun Kwon
Feb 3, 2007·Obstetrics and Gynecology·Elisabeth A EreksonDeborah L Myers
May 9, 2019·Neurourology and Urodynamics·Ervin KocjancicÖmer Acar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.